Abstract
Moyamoya disease is progressive occlusion of bilateral distal carotid arteries with the formation of collateral circulations. There is critical balance between perfusion delay and stress. Although the cause of Moyamoya disease has been still under investigation, there are debates about the most effective treatment method especially between indirect and direct revascularization. Ischemic attacks and hemorrhage are two major problems of this complicated disease. Revascularization is one of the methods of choice to prevent further ischemic insults but still debating its efficacy on hemorrhagic attack. Repeated ischemic and hemorrhagic insults will accumulate damages in the brain and deteriorate the neurological and functional status of Moyamoya patients. Due to its progressive nature, early diagnosis and timely management for repeated attack, whether it could be ischemic or hemorrhagic, are tremendously important. The critical treatment for the cause of Moyamoya disease hopes to come soon.
References
Adelson PD, Scott RM (1995) Pial synangiosis for Moyamoya syndrome in children. Pediatr Neurosurg 23(1):26–33
Albala MM, Levine PH (1984) Platelet factor 4 and beta thromboglobulin in Moya-Moya disease. Am J Pediatr Hematol Oncol 6(1):96–99
Amano T, Inoha S, Wu CM, Matsushima T, Ikezaki K (2003) Serum alpha1-antitrypsin level and phenotype associated with familial Moyamoya disease. Childs Nerv Syst 19(9):655–658
Aoyagi M, Fukai N, Sakamoto H, Shinkai T, Matsushima Y, Yamamoto M, Yamamoto K (1991) Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with Moyamoya disease. J Cell Physiol 147(2):191–198
Aoyagi M, Fukai N, Matsushima Y, Yamamoto M, Yamamoto K (1993) Kinetics of 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with Moyamoya disease. J Cell Physiol 154(2):281–288
Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K (1996) Early development of intimal thickening in superficial temporal arteries in patients with Moyamoya disease. Stroke 27(10):1750–1754
Aoyagi M, Fukai N, Yamamoto M, Matsushima Y, Yamamoto K (1997) Development of intimal thickening in superficial temporal arteries in patients with Moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S213–S217
Asfora WT, West M, McClarty B (1993) Angiography of encephalomyosynangiosis and superficial temporal artery to middle cerebral artery anastomosis in Moyamoya disease. AJNR Am J Neuroradiol 14(1):29–30
Boone SC, Sampson DS (1978) Observations on Moyamoya disease: a case treated with superficial temporal-middle cerebral artery anastomosis. Surg Neurol 9(3):189–193
Chabbert V, Ranjeva JP, Sevely A, Boetto S, Berry I, Manelfe C (1998) Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya. Neuroradiology 40(4):267–271
Chang KH, Yi JG, Han MH, Kim IO (1990) MR imaging findings of Moyamoya disease. J Korean Med Sci 5(2):85–90
Choi JU, Kim DS, Kim EY, Lee KC (1997) Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 99(Suppl 2):S11–S18
Demartini Z, Martins R, Rocha C, Matos L, Spotti A, Tognola W, Santos M (2008) Surgical treatment of Moyamoya disease in children. Arq Neuropsiquiatr 66(2):276
Fujiwara J, Nakahara S, Enomoto T, Nakata Y, Takita H (1996) The effectiveness of O2 administration for transient ischemic attacks in Moyamoya disease in children. Childs Nerv Syst 12(2):69–75
Fukuyama Y, Umezu R (1985) Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (“Moyamoya” disease) in children. Brain Dev 7(1):21–37
Fung LW, Thompson D, Ganesan V (2005) Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 21(5):358–364
Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM (2009) Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84(5):617–627
Haines D (1991) On the question of a subdural space. Anat Rec 230:3–21
Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, Choi SG, Doh JO, Han JW, Jung S, Kang SD, Kim DJ, Kim HI, Kim HD, Kim MC, Kim SC, Kim SC, Kim Y, Kwun BD, Lee BG, Lim YJ, Moon JG, Park HS, Shin MS, Song JH, Suk JS, Yim MB (2000) A co-operative study: clinical characteristics of 334 Korean patients with Moyamoya disease treated at neurosurgical institutes (1976–1994). The Korean society for cerebrovascular disease. Acta Neurochir (Wien) 142(11):1263–1273. discussion 1273–1264
Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, Watanabe A, Kasahara T, Sudo T, Shiota F, Hashikata H, Takagi Y, Morito D, Miyamoto S, Nakao K, Koizumi A (2013) Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>a) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from Moyamoya patients. Biochem Biophys Res Commun 438(1):13–19
Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M (1991) Possible roles of basic fibroblast growth factor in the pathogenesis of Moyamoya disease: an immunohistochemical study. J Neurosurg 75(2):267–270
Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S (1996) Surgical therapy for adult Moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27(8):1342–1346
Houkin K, Ishikawa T, Yoshimoto T, Abe H (1997) Direct and indirect revascularization for Moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99(Suppl 2):S142–S145
Ikeda E (1991) Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 22(11):1358–1362
Ikeda E, Hosoda Y (1992) Spontaneous occlusion of the circle of Willis (cerebrovascular Moyamoya disease): with special reference to its clinicopathological identity. Brain Dev 14(4):251–253
Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T (1999) Mapping of a familial Moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64(2):533–537
Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M (1994) Cerebral circulation and oxygen metabolism in childhood Moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81(6):843–850
Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y (1998) Long-term outcomes of pediatric Moyamoya disease monitored to adulthood. Pediatr Neurol 18(4):321–325
Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M (2000) Linkage analysis of Moyamoya disease on chromosome 6. J Child Neurol 15(3):179–182
Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H (2002) Long-term outcomes of pediatric Moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg 36(1):14–21
Iwama T, Hashimoto N, Tsukahara T, Murai B (1995) Peri-operative complications in adult Moyamoya disease. Acta Neurochir (Wien) 132(1–3):26–31
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56(1):34–40
Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC (2006) Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial Moyamoya disease. Neurosurgery 58(6):1074–1080. discussion 1074–1080
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J Neurol Neurosurg Psychiatry 81(6):673–678
Karasawa J, Kikuchi H, Furuse S, Sakaki T, Yoshida Y (1977) A surgical treatment of “Moyamoya” disease “encephalo-myo synangiosis”. Neurol Med Chir (Tokyo) 17(1 Pt 1):29–37
Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T (1978) Treatment of Moyamoya disease with STA-MCA anastomosis. J Neurosurg 49(5):679–688
Karasawa J, Kikuchi H, Kawamura J, Sakai T (1980) Intracranial transplantation of the omentum for cerebrovascular Moyamoya disease: a two-year follow-up study. Surg Neurol 14(6):444–449
Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H (1992) Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 77(1):84–89
Kashiwagi S, Kato S, Yasuhara S, Wakuta Y, Yamashita T, Ito H (1996) Use of a split dura for revascularization of ischemic hemispheres in Moyamoya disease. J Neurosurg 85(3):380–383
Katz DA, Marks MP, Napel SA, Bracci PM, Roberts SL (1995) Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology 195(2):445–449
Kim SK, Wang KC, Kim IO, Lee DS, Cho BK (2002) Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery 50(1):88–96
Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, Kim JH, Chung YN, Wang KC (2003) Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 34(12):2835–2841
Kim SH, Choi JU, Yang KH, Kim TG, Kim DS (2005) Risk factors for postoperative ischemic complications in patients with Moyamoya disease. J Neurosurg 103(Suppl 5):433–438
Kinugasa K, Mandai S, Kamata I, Sugiu K, Ohmoto T (1993) Surgical treatment of Moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms. Neurosurgery 32(4):527–531
Kitahara T, Okumura K, Semba A, Yamaura A, Makino H (1982) Genetic and immunologic analysis on Moya-moya. J Neurol Neurosurg Psychiatry 45(11):1048–1052
Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J (1979) Electroencephalographic findings in children with Moyamoya disease. Arch Neurol 36(1):16–19
Kono S, Oka K, Sueishi K (1990) Histopathologic and morphometric studies of leptomeningeal vessels in Moyamoya disease. Stroke 21(7):1044–1050
Kurokawa T, Chen YJ, Tomita S, Kishikawa T, Kitamura K (1985a) Cerebrovascular occlusive disease with and without the Moyamoya vascular network in children. Neuropediatrics 16(1):29–32
Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K (1985b) Prognosis of occlusive disease of the circle of Willis (Moyamoya disease) in children. Pediatr Neurol 1(5):274–277
Lee SK, Kim DI, Jeong EK, Kim SY, Kim SH, In YK, Kim DS, Choi JU (2003) Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 24(4):741–747
Lee JY, Moon YJ, Lee HO, Park AK, Choi SA, Wang KC, Han JW, Joung JG, Kang HS, Kim JE, Phi JH, Park WY, Kim SK (2015) Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric Moyamoya disease. Arterioscler Thromb Vasc Biol 35(7):1670–1677
Li H, Zhang ZS, Liu W, Yang WZ, Dong ZN, Ma MJ, Han C, Yang H, Cao WC, Duan L (2010) Association of a functional polymorphism in the MMP-3 gene with Moyamoya disease in the Chinese Han population. Cerebrovasc Dis 30(6):618–625
Lin Y, Yoshiko K, Negoro T, Watanabe K, Negoro M (2000) Cerebral oxygenation state in childhood Moyamoya disease: a near-infrared spectroscopy study. Pediatr Neurol 22(5):365–369
Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, Kobayashi H, Kikuta K, Takagi Y, Hitomi T, Krischek B, Zou LP, Fang F, Herzig R, Kim JE, Kang HS, Oh CW, Tregouet DA, Hashimoto N, Koizumi A (2010) A rare Asian founder polymorphism of raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med 15(2):94–104
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for Moyamoya disease and its possible role in vascular development. PLoS One 6(7):e22542
Maki Y, Enomoto T (1988) Moyamoya disease. Childs Nerv Syst 4(4):204–212
Malek AM, Connors S, Robertson RL, Folkman J, Scott RM (1997) Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in Moyamoya and central nervous system disorders. Pediatr Neurosurg 27(4):182–189
Matsushima Y, Inaba Y (1986) The specificity of the collaterals to the brain through the study and surgical treatment of Moyamoya disease. Stroke 17(1):117–122
Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, Ohno K (1981) A new surgical treatment of Moyamoya disease in children: a preliminary report. Surg Neurol 15(4):313–320
Matsushima Y, Aoyagi M, Masaoka H, Suzuki R, Ohno K (1990a) Mental outcome following encephaloduroarteriosynangiosis in children with Moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst 6(8):440–443
Matsushima Y, Aoyagi M, Niimi Y, Masaoka H, Ohno K (1990b) Symptoms and their pattern of progression in childhood Moyamoya disease. Brain Dev 12(6):784–789
Mineharu Y, Takagi Y, Takahashi JC, Hashikata H, Liu W, Hitomi T, Kobayashi H, Koizumi A, Miyamoto S (2013) Rapid progression of unilateral Moyamoya disease in a patient with a family history and an RNF213 risk variant. Cerebrovasc Dis 36(2):155–157
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of Moyamoya disease. Neurology 78(11):803–810
Mizoi K, Kayama T, Yoshimoto T, Nagamine Y (1996) Indirect revascularization for Moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol 45(6):541–548. discussion 548–549
Nakagawa Y, Tsuru M, Gotho S, Shimoyama M (1984) Reconstructive surgery in Moyamoya disease with hemorrhage attacks: does surgical intervention reduce the risk for repeated bleeding. In: Kikuchi H, Handa H, Yonekawa Y (eds) Microsurgical anastomosis for cerebral ischemia. Igaku-Shoin, Tokyo, pp 233–239
Nomura S, Kashiwagi S, Uetsuka S, Uchida T, Kubota H, Ito H (2001) Perioperative management protocols for children with Moyamoya disease. Childs Nerv Syst 17(4–5):270–274
Ogawa A, Yoshimoto T, Suzuki J, Sakurai Y (1990) Cerebral blood flow in Moyamoya disease. Part 1: correlation with age and regional distribution. Acta Neurochir (Wien) 105(1–2):30–34
Ohaghbulam CMS, Scott. R (2001) Moyamoya syndrome. In: McLone D (ed) Pediatric neruosurgery. WB Saunders, Philadelphia, pp 1077–1092
Ohta T, Tanaka H, Kuroiwa T (1995) Diffuse leptomeningeal enhancement, “ivy sign,” in magnetic resonance images of Moyamoya disease in childhood: case report. Neurosurgery 37(5):1009–1012
Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C (1998) Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult Moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29(3):625–630
Ozgur BM, Aryan HE, Levy ML (2006) Indirect revascularisation for paediatric Moyamoya disease: the EDAMS technique. J Clin Neurosci 13(1):105–108
Robertson RL, Chavali RV, Robson CD, Barnes PD, Eldredge EA, Burrows PE, Scott RM (1998) Neurologic complications of cerebral angiography in childhood Moyamoya syndrome. Pediatr Radiol 28(11):824–829
Saeki N, Yamaura A, Hoshi S, Sunami K, Ishige N, Hosoi Y (1991) Hemorrhagic type of Moyamoya disease. No Shinkei Geka 19(8):705–712
Sainte-Rose C, Oliveira R, Puget S, Beni-Adani L, Boddaert N, Thorne J, Wray A, Zerah M, Bourgeois M (2006) Multiple bur hole surgery for the treatment of Moyamoya disease in children. J Neurosurg 105(Suppl 6):437–443
Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J (1997) Risk factors for neurologic deterioration after revascularization surgery in patients with Moyamoya disease. Anesth Analg 85(5):1060–1065
Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, Arinami T (2004) A novel susceptibility locus for Moyamoya disease on chromosome 8q23. J Hum Genet 49(5):278–281
Scott RM (2000) Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient. Clin Neurosurg 47:378–384
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with Moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(Suppl 2 Pediatrics):142–149
Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK (2006) Familial occurrence of Moyamoya disease: a clinical study. Childs Nerv Syst 22(9):1143–1148
Soriano SG, Sethna NF, Scott RM (1993) Anesthetic management of children with Moyamoya syndrome. Anesth Analg 77(5):1066–1070
Sunder TR, Erwin CW, Dubois PJ (1980) Hyperventilation induced abnormalities in the electroencephalogram of children with Moyamoya disease. Electroencephalogr Clin Neurophysiol 49(3–4):414–420
Suzui H, Hoshimaru M, Takahashi JA, Kikuchi H, Fukumoto M, Ohta M, Itoh N, Hatanaka M (1994) Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with Moyamoya disease. Neurosurgery 35(1):20–24. discussion 24–25
Suzuki J (1986) Moyamoya disease. Springer, Berlin
Suzuki J, Kodama N (1983) Moyamoya disease–a review. Stroke 14(1):104–109
Suzuki J, Takaku A (1969) Cerebrovascular “Moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288–299
Tagawa T, Naritomi H, Mimaki T, Yabuuchi H, Sawada T (1987) Regional cerebral blood flow, clinical manifestations, and age in children with Moyamoya disease. Stroke 18(5):906–910
Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H (1993) The cerebrospinal fluid in patients with Moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett 160(2):214–216
Takeuchi K, Shimizu K (1957) Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9:37–43
Taomoto K, Asada M, Kanazawa Y, Matsumoto S (1983) Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease. Stroke 14(4):518–524
Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y (1997) Epidemiological features of Moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99(Suppl 2):S1–S5
Yamada I, Suzuki S, Matsushima Y (1995) Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 196(1):211–218
Yamashita M, Oka K, Tanaka K (1983) Histopathology of the brain vascular network in Moyamoya disease. Stroke 14(1):50–58
Yamauchi T, Houkin K, Tada M, Abe H (1997) Familial occurrence of Moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S162–S167
Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M (2000) Linkage of familial Moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31(4):930–935
Yonekawa Y, Ogata N (1992) Spontaneous occlusion of the circle of Willis (cerebrovascular Moyamoya disease): with special reference to its disease entity and etiological controversy. Brain Dev 14(4):253–254
Yonekawa Y, Yasargil M (1977) Brain revascularization by transplanted omentum. A possible treatment of cerebral iscemia. Neurosurgery 1:256–259
Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG (1997) Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99(Suppl 2):S58–S60
Yoshioka N, Tominaga S, Suzuki Y, Yamazato K, Hirano S, Nonaka K, Inui T, Matuoka N (1998) Cerebral revascularization using omentum and muscle free flap for ischemic cerebrovascular disease. Surg Neurol 49(1):58–65. discussion 65–56
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Shim, K.W., Park, E.K., Choi, J.U., Kim, D.S. (2017). Moya-moya Disease. In: Di Rocco, C., Pang, D., Rutka, J. (eds) Textbook of Pediatric Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-31512-6_54-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31512-6_54-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31512-6
Online ISBN: 978-3-319-31512-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences